Connor, Clark & Lunn Investment Management Ltd. - NOVAVAX INC ownership

NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 324 filers reported holding NOVAVAX INC in Q2 2022. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of NOVAVAX INC
ValueSharesWeighting
Q1 2022$19,104,000
-27.3%
259,383
+41.3%
0.09%
-26.6%
Q4 2021$26,262,000
-31.4%
183,560
-0.7%
0.13%
-36.0%
Q3 2021$38,304,000
+167.2%
184,766
+173.6%
0.20%
+174.0%
Q2 2021$14,337,000
+122.1%
67,528
+89.7%
0.07%
+102.8%
Q1 2021$6,454,000
-6.8%
35,597
-42.7%
0.04%
-12.2%
Q4 2020$6,924,000
-3.2%
62,090
-6.0%
0.04%
-14.6%
Q3 2020$7,156,000
+92.7%
66,042
+48.3%
0.05%
+84.6%
Q2 2020$3,713,00044,5440.03%
Other shareholders
NOVAVAX INC shareholders Q2 2022
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 132,500$2,414,0000.77%
HAP Trading, LLC 130,000$10,673,0000.71%
Mendel Capital Management LLC 23,835$434,0000.51%
Faithward Advisors, LLC 115,912$2,109,0000.50%
Rock Springs Capital Management LP 599,300$10,907,0000.28%
SECTOR GAMMA AS 56,735$1,033,0000.27%
Quantitative Investment Management, LLC 83,072$1,511,0000.25%
LMR Partners LLP 396,100$7,209,0000.13%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 1,333,706$24,273,0000.13%
TSP Capital Management Group, LLC 16,025$292,0000.12%
View complete list of NOVAVAX INC shareholders